Researchers have provided initial and somewhat speculative data to suggest that the decrease in body temperature that occurs in old age may speed the progression of mechanisms implicated in Alzheimer's disease: "We know that the incidence of Alzheimer's is low before age 65, but doubles every 5 to 6 years afterward. Show More Summary
Mayo Clinic's Dr. Ron Petersen is one of several experts testifying on Capitol Hill today at 2:30 pm EDT. The U.S. Senate Special Committee on Aging is holding a hearing on Alzheimer’s disease:“Finding a Cure: Assessing Progress Toward the Goal of Ending Alzheimer’s by 2025”. WATCH LIVE at 2:30 p.m. EDT. Chairman Collins, Ranking Member McCaskill will examine […]
Periodontitis, an inflammatory condition of the gums, can spread the effects of chronic inflammation elsewhere in the body via the circulatory system. It is associated with the progression of a number of common age-related conditions that have an inflammatory component, such as cardiovascular disease. Show More Summary
This is an intriguing study in mice in which researchers explore exactly which structures must be regrown and recovered in the brain in order to restore access to memories lost to the progression of Alzheimer's disease - or, indeed, any other form of neurodegeneration. Show More Summary
Amsterdam, March 9, 2016 - A portable biosensor that could show how disease is progressing in patients with Alzheimer's could greatly improve people's quality of life in the future, according to a new review published in Biosensors and Bioelectronics. read more
Researchers have been discovering more and more about Alzheimer's disease, and some significant progress has been made in bettering our understanding of the degenerative condition. Now researchers from Lund University in Sweden haveShow More Summary
New research led by scientists at UC Berkeley shows for the first time that PET scans can track the progressive stages of Alzheimer's disease in cognitively normal adults, a key advance in the early diagnosis and staging of the neurodegenerative disorder.
Neuroscientists show for the first time that PET scans can track the progression of Alzheimer's disease. In doing so, they also shed light on tau and beta amyloid, two key proteins associated with the neurodegenerative disorder.
Berkeley -- New research led by scientists at the University of California, Berkeley, shows for the first time that PET scans can track the progressive stages of Alzheimer's disease in cognitively normal adults, a key advance in theShow More Summary
Researchers have reduced inflammation and cell death in a mouse model of Alzheimer's disease by reducing the numbers of microglia present in brain tissue, an approach that doesn't reduce amyloid-? levels associated with the progression of Alzheimer's disease even though it results in functional benefits. Show More Summary
The benefits of mental and physical activity on the aging brain are now well documented. However, the progression of Alzheimer's disease appears to follow its own rules.
Researchers have devised several lipid-based diets aimed at slowing down progression and relieving symptoms of Alzheimer's disease (AD). It is generally accepted that lifestyle and particularly dietary habits influence mental health, and prevalence and progression of AD. Show More Summary
Study of plaque production holds promise of helping improve treatment for Alzheimer's, say investigators. Focusing on the form of the disease found in early onset Alzheimer's, in the 2 percent of patients who develop the progressiveShow More Summary
Scientists studied 250 people with mild cognitive impairment: a condition that can progress to dementia.
An FDA approved blood pressure medication Atacand (candesartan) was shown to reduce cell damage linked to the progression of Alzheimer's disease, according to a new study. "We hypothesize that candesartan, or other members of the ARB...Show More Summary
A person does not die directly from Alzheimer's disease. Over time, and as Alzheimer's progresses, the body's immune system weakens, increasing susceptibility to infection and other causes of death related to the elderly.Typical complications...Show More Summary
Blocking a receptor in the brain responsible for regulating immune cells could protect against the memory and behavior changes seen in the progression of Alzheimer's disease. It was originally thought that Alzheimer's disease disturbs...Show More Summary
A University of Southampton-led study has found that blocking a receptor in the brain responsible for regulating immune cells could protect against the memory and behaviour changes seen in the progression of Alzheimer's disease. The research, published today in the journal Brain, was jointly funded by the MRC (Medical Research Council) and Alzheimer's Research UK. read more
Alzheimer’s is a progressive neurodegenerative disease, and seeing a loved one gradually lose control over his life and relationships, fail to recognize you, and become dependent on others just to carry out simple daily tasks is very painful. Alzheimer’s disease-associated dementia is so common that it has come to be viewed as a normal consequence […]
The Methuselah Foundation has a record of seed funding early stage biotech and medical companies that are undertaking novel work that is (a) relevant to aging or tissue repair and (b) not already in progress to any meaningful degree elsewhere. Show More Summary